The US Food and Drug Administration (FDA) has awarded breakthrough therapy designation to uniQure's AMT-130 for treating ...

Medial temporal lobectomy is effective in improving seizure outcomes among patients with drug-resistant temporal lobe epilepsy, according to a study published online March 6 in Cureus. In a ...

Vaclav Kremen, Ph.D., Mayo Clinic researcher and co-lead author of the study The researchers monitored five patients with temporal lobe epilepsy throughout their DBS treatment. The system allowed ...

Objective We sought to augment the presurgical workup of medically refractory temporal lobe epilepsy by creating a supervised machine learning technique that uses diffusion-weighted imaging to ...

The probability of receiving a pellet was larger in one lateral port (80 vs ... on epileptiform activity and cognitive function in a murine model of mesial temporal lobe epilepsy, prompted by KA ...

The asset, dubbed NRTX-1001, is currently being tested in an open-label phase 1/2 trial among patients with drug-resistant mesial temporal lobe epilepsy (MTLE), plus another phase 1/2 study for ...

In this study, we aimed to construct ferroptosis-related gene signatures in temporal lobe epilepsy with hippocampal sclerosis (TLE-HS) and explore their diagnostic role in TLE-HS. Methods: The ...